Vinnie Y.T. Liu

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial

Daniel E. Spratt, Vinnie Y.T. Liu, Jeff M. Michalski et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 34 citations · Full text

Medicine, Oncology, Urology +16

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials

Andrew J. Armstrong, Vinnie Y.T. Liu, Ramprasaath R. Selvaraju et al. · Journal of Clinical Oncology · 2025 · 21 citations · Full text

Medicine, Oncology, Urology +17

External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol

Charles Parker, Larissa Mendes, Vinnie Y.T. Liu et al. · The Lancet Digital Health · 2025 · 15 citations · Full text

Medicine, Oncology, Urology +17

Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy

Anders Bjartell, Agnieszka Krzyzanowska, Vinnie Y.T. Liu et al. · Clinical Cancer Research · 2025 · 12 citations · Full text

Medicine, Oncology, Urology +17

Impact of Decipher on use of post‐operative radiotherapy: Individual patient analysis of two prospective registries

Mohammed Shahait, Vinnie Y.T. Liu, Neha Vapiwala et al. · BJUI Compass · 2021 · 10 citations · Full text

Medicine, Oncology, Urology +14